vVARDIS Holding AG Class A (VVVV)
NYSE: VVVVHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VVVV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $770.91M
- EPS (TTM)
- -$0.29
- Dividend yield
- None
- 52-week range
- 14.00 – 16.95
- Day range
- 14.54 – 14.97
- Volume / Avg
- 341.52K / 963.08K
- Beta
- —
- Shares outstanding
- 38.59M
52-week range
VVVV stock today
Shares of vVARDIS (VVVV) finished lower on Nov 20 at $14.55, a drop of 3.00% or $0.45 per share, versus the S&P 500's 3.70% decline. Trading was light, with 341.52K shares changing hands, about 35% of the average daily volume. At this level, VVVV sits near the bottom of its 52-week range of $14.00 to $16.95: 14.2% below the high, set on Nov 16, 2026 and 3.9% above the low.
vVARDIS has posted a net loss over the last twelve months (EPS of -$0.29), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About vVARDIS
Company profilevVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel. The company was incorporated in 2020 and is based in Zug, Switzerland.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Dr. Goly Abivardi D.M.D.
- Headquarters
- Zug
- Employees
- 153
- IPO year
- 2026
- Website
- vvardis.com
VVVV news
All VVVV newsvVARDIS peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BBNXBeta Bionics Inc. | 13.36 | +0.30% | $726.34M | vs VVVV |
| KIDSOrthoPediatrics Corp. | 31.74 | -2.37% | $828.75M | vs VVVV |
| BVSBioventus Inc. Class A | 9.88 | -0.70% | $676.53M | vs VVVV |
| AORTArtivion Inc. | 18.16 | -2.00% | $886.02M | vs VVVV |
| DCTHDelcath Systems Inc. | 18.79 | -2.34% | $653.67M | vs VVVV |
| TCMDTactile Systems Technology Inc. | 25.60 | -1.50% | $573.48M | vs VVVV |
| SGHTSight Sciences Inc. | 10.18 | -4.14% | $565.79M | vs VVVV |
| SGPSpyGlass Pharma Inc. | 30.43 | -1.14% | $1.02B | vs VVVV |
Indexes, lists and sector
vVARDIS stock FAQ
What is vVARDIS's stock price today?
VVVV last traded at $14.55 as of Nov 20, 4:00 PM EST, down 3.00% on the day. Prices are delayed at least 15 minutes.
Who is vVARDIS's CEO?
Dr. Goly Abivardi D.M.D. is the chief executive officer of vVARDIS Holding AG Class A, which has about 153 employees.
What is the VVVV 52-week high?
The 52-week high for VVVV is $16.95 and the 52-week low is $14.00. The stock is currently 14.2% below its high.